Enterprise of Rosatom State Corporation
Print version
Main | Company news

Company news

09/11/2021
ROSATOM takes part in “Clean Nuclear Energy Day” events at COP26

8 November 2021, Glasgow, UK – “Clean Nuclear Energy Day” took place on November 8 as part of the twenty-sixth session of the Conference of the Parties (COP26), held in the United Nations Framework Convention on Climate Change (UNFCCC). The special “Clean Nuclear Energy Day” programme was made possible with ROSATOM’s support.

24/10/2021
Isotope JSC - partner of the EANM Congress 2021

Isotope JSC participated in 34th Annual Congress of the European Association of Nuclear Medicine on October 20-23, 2021. Due to the pandemic, the congress was held virtually for the second year in a row.

04/10/2021
ROSATOM’s Sustainable Development Report posted on the website of the UN Global Compact Network for the first time

The ROSATOM’s first Sustainable Development Report for 2020 was first posted on the website of the UN Global Compact Network October 1, 2021. The report is qualified rated at level “Active”.

09/09/2021
Isotope JSC took part in the Brazilian Congress of Nuclear Medicine 2021

ROSATOM took part in the XXXV Brazilian Congress of Nuclear Medicine (CBMN) as a Gold Sponsor. The event took place in Brazil on September, 3-6. Due to the coronavirus pandemic, the event was held virtually.

06/09/2021
Isotope JSC experts participated in the oncological conference in Italy

On September, 2-4 representatives of Isotope JSC took part in the second Russian-Italian scientific conference "Challenges of oncology in the era of COVID-19 ", held in a hybrid format in Taranto (Italy).

30/07/2021
Isotope JSC took part in the international Nuclear Trade and Technology Exchange (NT2E) conference

ROSATOM took part in the international online conference Nuclear Trade and Technology Exchange (NT2E), organized by the Brazilian Association for the Development of Nuclear Activities (ABDAN) on July 27-29, 2021.

09/06/2021
ROSATOM to supply Brazil with promising isotopes needed in Nuclear Medicine

Isotope JSC (a part of Rusatom Healthcare JSC, Rosatom’s radiation technologies integrator) has signed a five-year contract with Brazil’s Nuclear and Energy Research Institute (IPEN; linked to the National Nuclear Energy Commission or CNEN) to supply lutetium-177 and actinium-225, the most promising medical isotopes in Radiopharma.

27/02/2021
Rosatom facility gains record revenues from stable isotopes sales

In 2020, revenue from sales of stable isotopes manufactured by Electrochemical Plant JSC (an enterprise of ROSATOM’s TVEL Fuel Company in Zelenogorsk, Krasnoyarsk region) increased by 14% year on year, exceeding 1.5 billion rubles for the first time.

22/10/2020
ROSATOM and Apulia continue cooperation by testing lutetium-177 used in cancer treatment

Isotope JSC, official distributor of isotope products manufactured by ROSATOM’s enterprises, successfully delivered lutetium-177 produced according to EU GMP standards to Nuclear Medicine Department of Policlinico of Bari (Apulia, Italy) for quality evaluation. The activity was implemented within the scope of the Healthcare Memorandum of Understanding signed between Apulia Region and ROSATOM in November 2019.

20/10/2020
Isotope JSC at EANM Virtual Congress

Come to see us at our virtual booth!